论文部分内容阅读
左旋多巴类制剂包括美多巴和息宁等药 ,临床上用于改善帕金森病 (PD)的症状和提高患者生活质量。其问世以来一直是PD治疗中最常用和最有效的药物 ,甚至被认为是帕金森病诊断与治疗的“金标准” ,许多其它针对帕金森病的治疗往往都是以左旋多巴治疗有效为前提和基础的[1 ] 。但
Levodopa preparations include drugs like meclopa and quinine, which are clinically used to ameliorate the symptoms of Parkinson’s disease (PD) and improve the quality of life of patients. It has been the most commonly used and most effective drug in the treatment of PD since its introduction and is even considered the “gold standard” for the diagnosis and treatment of Parkinson’s disease. Many other treatments for Parkinson’s disease are often based on the efficacy of levodopa Premise and basis [1]. but